1. Anti‐IL‐7 receptor α monoclonal antibody (GSK2618960) in healthy subjects – a randomized, double‐blind, placebo‐controlled study. Issue 2 (3rd December 2018) Authors: Ellis, Joanne; van Maurik, Andre; Fortunato, Lea; Gisbert, Sophie; Chen, Keguan; Schwartz, Ann; McHugh, Simon; Want, Andrew; Santos Franco, Sara; Oliveira, Joao‐Joaquim; Price, Jeffrey; Coles, Alasdair; Brown, Kim; Su, Donggang; Craigen, Jenny L.; Yang, Jiansong; Brett, Sara; Davis, Bill; Cheriya... Journal: British journal of clinical pharmacology Issue: Volume 85:Issue 2(2019) Page Start: 304 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Target engagement and cellular fate of otelixizumab: a repeat dose escalation study of an anti‐CD3ε mAb in new‐onset type 1 diabetes mellitus patients. Issue 4 (5th February 2019) Authors: Vlasakakis, Georgios; Napolitano, Antonella; Barnard, Ruth; Brown, Kim; Bullman, Jonathan; Inman, David; Keymeulen, Bart; Lanham, David; Leirens, Quentin; MacDonald, Alexander; Mezzalana, Enrica; Page, Kevin; Patel, Minesh; Savage, Caroline O.; Zamuner, Stefano; van Maurik, Andre Journal: British journal of clinical pharmacology Issue: Volume 85:Issue 4(2019) Page Start: 704 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗